Back to search

Article

Clinical and biochemical characteristics of schizophrenia patients with and without COVID-19: A retrospective study

2023-09-09

Abstract excerpt

<h4>Background: </h4> Previous studies have shown that patients with mental diseases such as schizophrenia are at high risk of coronavirus disease 2019 (COVID-19). However, the clinical characteristics of patients with schizophrenia and COVID-19 remain unknown. The aim of this study was to investigate the differences in clinical biochemical values between schizophrenia patients with and without COVID-19. Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb5c42b5-e102-59f7-a314-b62a7c90a932
DOI
10.21203/rs.3.rs-3222646/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and biochemical characteristics of schizophrenia patients with and without COVID-19: A retrospective studyDOI 10.21203/rs.3.rs-3222646/v1
Disparities in Intensive Care Unit Admission and Mortality Among Patients with Schizophrenia and COVID-19: A National Cohort StudySemantic proximity
Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study.Semantic proximity
Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity
Anxiety and depression in community-dwelling patients with schizophrenia in China during the COVID-19 pandemicSemantic proximity
Recognition of Schizophrenia and Quality of Treatment During the Covid-19 Pandemic: A Danish Nationwide StudySemantic proximity
Global,regional,national burden of schizophrenia from 1990 to 2021,with projections of prevalence to 2035:findings from the Global Burden of Disease Study 2021Semantic proximity
The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal studySemantic proximity
Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Semantic proximity
Elevated brain-derived cell-free DNA among patients with first psychotic episode – a proof-of-concept studySemantic proximity
"Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity".Semantic proximity
Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning StudySemantic proximity
NGS-based mtDNA Profiling Could Reveal Genetic Alterations in Schizophrenia.Semantic proximity
Select a neighboring publication to make it the new centre.